Distance for Interscalene Block
What is the Maximal Effective Distance for Interscalene Block?
1 other identifier
observational
25
1 country
1
Brief Summary
Patients experience significant postoperative pain following shoulder surgery, Single shot interscalene block is used in ambulatory shoulder surgery for its advantages that include significant reduction in acute pain and analgesic requirements, prolonged time to first analgesic request, decreased incidence of nausea, as well as earlier hospital discharge.The process of nerve block requires several needle passes, with each of them being at risk of causing nerve injury either by direct trauma or intraneural injection even with the use of the ultrasound. These facts raised concerns and several authors stated that maybe the anesthesiologists should be more careful, keep a safe distance from the nerve, and inject the local anesthetics into fascial planes containing the nerve and not attempt to place the needle in close proximity to the nerve. This study is designed to determine the maximal effective distance away from the nerve for the injection to be effective.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Feb 2012
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2012
CompletedFirst Submitted
Initial submission to the registry
March 6, 2012
CompletedFirst Posted
Study publicly available on registry
April 2, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 24, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
March 26, 2014
CompletedJanuary 10, 2018
January 1, 2018
12 months
March 6, 2012
January 8, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Success of the inter-scalene block at 20 minutes after injection at a specific distance of the needle tip from the outer sheeth of the nerve
20 mins
Secondary Outcomes (7)
The onset time of sensory and motor block
the block success will be assessed for each patient every 5 min for 20 mins in the block room beginning when the needle exits the skin
The proportion of inadequate and failed blocks.
the block success will be assessed for each patient every 5 min for 20 mins in the block room beginning when the needle exits the skin
The duration of block, defined as the time from the completion of block performance to the time of the request for the first postoperative analgesic.
during the first 24 hours post operative
The amount of pain and level of satisfaction,
every 30 minutes starting at post anesthesia care unit admission till 120 minutes
The presence of a Claude-Bernard-Horner Syndrome
up to 24 hours post operative
- +2 more secondary outcomes
Eligibility Criteria
Patients undergoing shoulder surgery (shoulder arthroscopy or open shoulder surgery)
You may qualify if:
- ASA physical status I-III
- years of age, inclusive
- surgery less than 3 hours
You may not qualify if:
- contraindications to brachial plexus block (e.g., allergy to local anesthetics, coagulopathy, malignancy or infection in the area)
- existing neurological deficit in the area to be blocked
- pregnancy
- history of neck surgery or radiotherapy
- severe respiratory disease
- inability to understand the informed consent and demands of the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Toronto Western Hospital
Toronto, Ontario, M5T 2S8, Canada
Study Officials
- PRINCIPAL INVESTIGATOR
Richard Brull, MD, FRCPC
University of Toronto
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 6, 2012
First Posted
April 2, 2012
Study Start
February 1, 2012
Primary Completion
January 24, 2013
Study Completion
March 26, 2014
Last Updated
January 10, 2018
Record last verified: 2018-01